Immediate Impact
36 standout
Citing Papers
Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity
2025 Standout
Dendritic cell maturation in cancer
2025 Standout
Works of Kate Wilkinson being referenced
First-in-human phase 1 dose escalation study of HX009, a novel recombinant humanized anti-PD-1 and CD47 bispecific antibody, in patients with advanced malignancies.
2021
A first-in-human phase I dose escalation of YH001, an anti-CTLA-4 monoclonal antibody (mAb) in combination with toripalimab (anti-PD-1 mAb) in patients with advanced solid tumors.
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Kate Wilkinson | 54 | 14 | 13 | 30 | 26 | 24 | 105 | |
| Mathieu Simonin | 32 | 22 | 31 | 29 | 10 | 26 | 164 | |
| Jiannan Xu | 40 | 22 | 6 | 19 | 60 | 18 | 169 | |
| Yoshinao Takano | 64 | 45 | 18 | 35 | 37 | 30 | 173 | |
| Élise Dumas | 103 | 12 | 11 | 24 | 34 | 23 | 157 | |
| Eva Guerra | 78 | 12 | 13 | 27 | 23 | 21 | 133 | |
| Guochun Cao | 40 | 41 | 7 | 12 | 30 | 18 | 138 | |
| Yoshiro Asahina | 36 | 42 | 19 | 11 | 17 | 18 | 148 | |
| Rushin Patel | 104 | 18 | 13 | 21 | 21 | 33 | 191 | |
| I. А. Mikhailov | 74 | 26 | 22 | 19 | 25 | 23 | 101 | |
| Rayan Kaakati | 27 | 44 | 17 | 28 | 13 | 21 | 172 |
All Works
Login with ORCID to disown or claim papers
Loading papers...